We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04808362
Brief Title: Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours (MYCure)

First Submitted : March 16, 2021
First Submitted that Met QC Criteria : March 18, 2021
First Posted : March 22, 2021

Last Update Submitted that Met QC Criteria : September 27, 2022
Last Update Posted : September 28, 2022